Related Experiment Videos
Pulmonary embolism after transcatheter arterial chemoembolization.
1Division of Cancer Research, National Health Research Institutes, Taipei, Taiwan. hsshiah@nhri.org.tw
European Journal of Cancer Care
|November 9, 2005
Summary
Transcatheter arterial chemoembolization (TACE) can treat liver tumors but rarely causes fatal pulmonary embolism. This case highlights a renal cell carcinoma patient who recovered fully after this rare TACE complication.
Area of Science:
- Oncology
- Interventional Radiology
- Pulmonology
Background:
- Transcatheter arterial chemoembolization (TACE) is a standard treatment for metastatic hepatic tumors.
- Common TACE complications include hepatic insufficiency, fever, and pain.
- Pulmonary embolism is a rare but potentially fatal adverse event associated with TACE.
Observation:
- A patient with renal cell carcinoma and liver metastases underwent TACE.
- The patient subsequently developed a pulmonary embolism, a rarely documented complication.
Findings:
- This case report details a pulmonary embolism occurring after TACE in a patient with metastatic renal cell carcinoma.
- The patient received effective treatment for the pulmonary embolism.
Implications:
- Highlights the importance of recognizing and managing rare complications like pulmonary embolism after TACE.
- Emphasizes the need for vigilance in patients undergoing TACE, particularly those with significant comorbidities.
- Suggests that prompt and effective treatment can lead to favorable outcomes even in rare adverse events.